120 related articles for article (PubMed ID: 1905150)
1. Phase II trial of ifosfamide in recurrent and metastatic head and neck cancer.
Buesa JM; Fernández R; Esteban E; Estrada E; Barón FJ; Palacio I; Gracia M; Lacave AJ
Ann Oncol; 1991 Feb; 2(2):151-2. PubMed ID: 1905150
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
Huber MH; Lippman SM; Benner SE; Shirinian M; Dimery IW; Dunnington JS; Hong WK
Am J Clin Oncol; 1996 Aug; 19(4):379-82. PubMed ID: 8677909
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Shin DM; Khuri FR; Glisson BS; Ginsberg L; Papadimitrakopoulou VM; Clayman G; Lee JJ; Ang KK; Lippman SM; Hong WK
Cancer; 2001 Apr; 91(7):1316-23. PubMed ID: 11283932
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of high-dose ifosfamide as a single agent and in combination with cisplatin in the treatment of advanced and/or recurrent squamous cell carcinoma of head and neck.
Pai VR; Parikh DM; Mazumdar AT; Rao RS
Oncology; 1993; 50(2):86-91. PubMed ID: 8451041
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Thurnher D; Kornfehl J; Burian M; Gedlicka C; Selzer E; Quint C; Neuchrist C; Kornek GV
Anticancer Drugs; 2001 Mar; 12(3):205-8. PubMed ID: 11290867
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.
Cervellino JC; Araujo CE; Pirisi C; Francia A; Cerruti R
Oncology; 1991; 48(2):89-92. PubMed ID: 1900124
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck: a phase II Hoosier Oncology Group trial.
Sandler A; Saxman S; Bandealy M; Heilman D; Monaco F; McClean J; Arquette M
Am J Clin Oncol; 1998 Apr; 21(2):195-7. PubMed ID: 9537211
[TBL] [Abstract][Full Text] [Related]
10. A phase 2 trial of ifosfamide/mesna as salvage therapy in patients with ovarian cancer refractory to or relapsing after prior platinum-containing chemotherapy.
Sørensen P; Pfeiffer P; Bertelsen K
Gynecol Oncol; 1995 Jan; 56(1):75-8. PubMed ID: 7821851
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide in advanced epidermoid head and neck cancer.
Martín M; Diaz-Rubio E; González Larriba JL; Casado A; Sastre J; López-Vega JM; Almenarez J; Dominguez S
Cancer Chemother Pharmacol; 1993; 31(4):340-2. PubMed ID: 8422700
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.
Sutton GP; Blessing JA; Homesley HD; Berman ML; Malfetano J
J Clin Oncol; 1989 Nov; 7(11):1672-6. PubMed ID: 2509641
[TBL] [Abstract][Full Text] [Related]
14. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
[TBL] [Abstract][Full Text] [Related]
15. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).
Sutton GP; Blessing JA; Rosenshein N; Photopulos G; DiSaia PJ
Am J Obstet Gynecol; 1989 Aug; 161(2):309-12. PubMed ID: 2548382
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
[TBL] [Abstract][Full Text] [Related]
19. Epidoxorubicin plus ifosfamide in advanced and/or metastatic soft-tissue sarcomas.
Toma S; Coialbu T; Biassoni L; Folco U; Gatti C; Canavese G; Giacchero A; Rosso R
Cancer Chemother Pharmacol; 1990; 26(6):453-6. PubMed ID: 2121378
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
Recchia F; Lalli A; Lombardo M; De Filippis S; Saggio G; Fabbri F; Rosselli M; Capomolla E; Rea S
Cancer; 2001 Aug; 92(4):814-21. PubMed ID: 11550152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
